tiprankstipranks

Outlook Therapeutics price target lowered to $1.50 from $2 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Outlook Therapeutics to $1.50 from $2 and keeps a Buy rating on the shares. The analyst cites a greater issuance of shares from the financing for the target drop.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on OTLK:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue